Tuesday, February 24, 2015

"Anti-Aging Experts Made a Million-Dollar Bet on Who Dies Last"

From Gizmodo:
Even 10 years ago, the idea of reversing aging and conquering human mortality was still fringe science, seen as snake-oil research by most scientists, large pharmaceutical companies, and the public. What a difference a decade makes. Anti-aging science is poised to become a major industry in the biotech world.

To prove its promise, the first million-dollar bet on who can live the longest (for company stock—a signed deal likely made public later this week) was recently struck. It was made last month by two leading longevity advocates at the biggest annual healthcare investing event of the year, the JPMorgan Health Care Conference.

Dmitry Kaminskiy, senior partner of Hong Kong-based technology venture fund, Deep Knowledge Ventures, and Dr. Alex Zhavoronkov, PhD, CEO of bioinformatics company Insilico Medicine Inc. which specializes in drug discovery and drug repurposing for aging and age-related diseases, signed a wager to indicate exactly how sure they are that science is turning the tide against the eternal problem of human aging.
The terms go like this:
- If one of the parties passes away before the other, $1 million dollars in Insilico Medicine stock will be passed to the surviving party
- The agreement will vest once both parties reach 100 years
- Parties agree not to accelerate each other's demise (i.e. try to kill each other)
...MORE